Bio-Techne
TECH
#2562
Rank
NZ$11.83 B
Marketcap
NZ$75.58
Share price
2.61%
Change (1 day)
-8.91%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): NZ$1.24

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$1.21. In 2025 the company made an earnings per share (EPS) of NZ$0.88 a decrease over its 2024 EPS that were of NZ$1.70.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.2440.02%
2025NZ$0.88-48%
2024NZ$1.70-29.58%
2023NZ$2.42-14.97%
2022NZ$2.8424.16%
2021NZ$2.2917.98%
2020NZ$1.94-10.94%
2019NZ$2.18101.57%
2018NZ$1.08-16.99%
2017NZ$1.3045.02%
2016NZ$0.90-20.97%
2015NZ$1.14-14.97%
2014NZ$1.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$30.99 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.29 669.01%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$13.93 1,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$8.83 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.50 190.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.36-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$10.39 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA